Dynavax Technologies Corp reports results for the quarter ended March 31 - Earnings Summary

Dynavax Technologies

06/05/2025 22:02

Dynavax Technologies Corp DVAX.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -7 cents.  The mean expectation of five analysts for the quarter was for earnings of 4 cents per share. Wall Street expected results to range from 3 cents to 6 cents per share.

Revenue rose 34.2% to $68.16 million from a year ago; analysts expected $69.58 million.

Dynavax Technologies Corp's reported EPS for the quarter was a loss of 77 cents​.

The company reported a quarterly loss of $96.1 million.

Dynavax Technologies Corp shares had fallen by 13.2% this quarter and lost 11.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 145% in the last three months.​

In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Dynavax Technologies Corp is $25.00

This summary was machine generated from LSEG data May 6 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
0.04
0.01
Missed
Dec. 31 2024
0.04
0.05
Beat
Sep. 30 2024
0.11
0.12
Beat
Jun. 30 2024
0.06
0.08
Beat